Get Form Sgnrhaovaplant-1 Report On Receipt Of Drug - Guide For Reporting - Fws

The Form SGnRHaOvaplant-1 is essential for investigators handling the receipt of investigational new animal drugs for poikilothermic food animals. This guide provides a clear, step-by-step approach to assist users in accurately completing the form online.

Follow the steps to successfully complete the form online:

1. Press the ‘Get Form’ button to retrieve the Form SGnRHaOvaplant-1 and open it in the editor.
2. Begin by filling out the name of the drug, which in this context is sGnRHa (Ovaplant®). Ensure you provide the correct information as it is crucial for reporting.
3. Enter the INAD number, which is 11-375 for this specific drug.
4. Specify the proposed use of the drug. It is intended to induce gamete maturation in a variety of fish species.
5. Record the date of the Center for Veterinary Medicine (CVM) authorization letter, which is December 15, 2005.
6. Indicate the source of the drug, in this case, Syndel International, Inc.
7. Fill in the date of drug receipt, ensuring to note the exact day the drug was received.
8. Document the amount of drug received, making sure the measurement aligns with the received shipment.
9. Enter the drug lot number, which is necessary for tracking purposes.
10. Input the study worksheet number, which relates to the ongoing research project.
11. Provide the name and address of the investigator, ensuring that these details are current and accurate.
12. Indicate the location of the trial, providing sufficient details for future reference.
13. Answer whether the study is pivotal by selecting 'yes' or 'no', as this affects regulatory compliance.
14. Outline the approximate number of treated animals involved in the study.
15. Similarly, detail the number of control animals used for comparative purposes.
16. If applicable, input the number of animals used previously in any related studies, which may be relevant for your findings.
17. Specify the study protocol number, if relevant, which usually correlates to internal documentation.
18. Fill in the approximate dates of the trial, including both start and end dates, for clarity in timeline understanding.
19. Identify the species, size, and type of animals involved in the trial to capture pertinent experimental details.
20. Record the maximum total dose to be administered based on the established protocol.
21. Describe the methods of administration employed in the trial to provide insight into procedural approaches.
22. Enter the withdrawal period, essential for determining any time frames before animals can be released.
23. Ensure that both the investigator and study monitor sign and date the form at the designated locations.
24. After completing the form, check for accuracy, then save your changes, and you may also choose to download, print, or share the form for further action.

Complete your documentation online today to ensure compliance and accuracy.